Trade Mark Journal No.2025/036 5 September 2025
UK00004253260 22 August 2025 (5)

International priority date claimed: 25 February 2025
(United States of America)
(99056143)
- Class 5
- Medicated and pharmaceutical preparations for the treatment and prevention of migraines; medicated and pharmaceutical preparations for the treatment and prevention of neurological disorders.
Axsome Therapeutics, Inc.
Representative: Keltie LLP